Geode Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.41M Sell
666,191
-186,515
-22% -$394K ﹤0.01% 3234
2025
Q1
$1.04M Sell
852,706
-17,883
-2% -$21.8K ﹤0.01% 3299
2024
Q4
$1.12M Buy
870,589
+8,047
+0.9% +$10.4K ﹤0.01% 3330
2024
Q3
$2.37M Buy
862,542
+20,817
+2% +$57.3K ﹤0.01% 3067
2024
Q2
$1.9M Buy
841,725
+274,564
+48% +$621K ﹤0.01% 3139
2024
Q1
$1.36M Buy
567,161
+52,745
+10% +$126K ﹤0.01% 3249
2023
Q4
$854K Buy
514,416
+3,985
+0.8% +$6.62K ﹤0.01% 3410
2023
Q3
$980K Sell
510,431
-11,855
-2% -$22.8K ﹤0.01% 3328
2023
Q2
$752K Buy
522,286
+608
+0.1% +$876 ﹤0.01% 3464
2023
Q1
$1.1M Buy
521,678
+7,863
+2% +$16.5K ﹤0.01% 3306
2022
Q4
$580K Sell
513,815
-87
-0% -$98 ﹤0.01% 3594
2022
Q3
$837K Buy
513,902
+2,763
+0.5% +$4.5K ﹤0.01% 3485
2022
Q2
$669K Sell
511,139
-47,101
-8% -$61.6K ﹤0.01% 3603
2022
Q1
$898K Sell
558,240
-1,488
-0.3% -$2.39K ﹤0.01% 3667
2021
Q4
$1.16M Buy
559,728
+18,862
+3% +$39K ﹤0.01% 3645
2021
Q3
$2.1M Buy
540,866
+131,853
+32% +$511K ﹤0.01% 3323
2021
Q2
$1.31M Sell
409,013
-236,854
-37% -$757K ﹤0.01% 3467
2021
Q1
$1.4M Buy
645,867
+3,763
+0.6% +$8.16K ﹤0.01% 3420
2020
Q4
$1.44M Buy
642,104
+47,483
+8% +$106K ﹤0.01% 3242
2020
Q3
$1.59M Buy
594,621
+921
+0.2% +$2.46K ﹤0.01% 3000
2020
Q2
$1.82M Buy
593,700
+32,332
+6% +$98.9K ﹤0.01% 2900
2020
Q1
$1.1M Buy
561,368
+16,795
+3% +$32.9K ﹤0.01% 2984
2019
Q4
$1.56M Buy
544,573
+74,017
+16% +$212K ﹤0.01% 3111
2019
Q3
$1.73M Buy
470,556
+1,493
+0.3% +$5.48K ﹤0.01% 3018
2019
Q2
$1.95M Buy
469,063
+189,315
+68% +$785K ﹤0.01% 2970
2019
Q1
$1.43M Buy
279,748
+52,573
+23% +$269K ﹤0.01% 3019
2018
Q4
$779K Buy
227,175
+15,410
+7% +$52.8K ﹤0.01% 3210
2018
Q3
$1.27M Buy
211,765
+9,202
+5% +$55.3K ﹤0.01% 3115
2018
Q2
$1.29M Buy
202,563
+7,152
+4% +$45.5K ﹤0.01% 3079
2018
Q1
$926K Hold
195,411
﹤0.01% 3153
2017
Q4
$652K Hold
195,411
﹤0.01% 3260
2017
Q3
$414K Hold
195,411
﹤0.01% 3428
2017
Q2
$480K Buy
195,411
+86,400
+79% +$212K ﹤0.01% 3368
2017
Q1
$250K Buy
109,011
+774
+0.7% +$1.78K ﹤0.01% 3576
2016
Q4
$106K Buy
108,237
+516
+0.5% +$505 ﹤0.01% 3778
2016
Q3
$121K Buy
107,721
+129
+0.1% +$145 ﹤0.01% 3761
2016
Q2
$158K Hold
107,592
﹤0.01% 3664
2016
Q1
$153 Sell
107,592
-129
-0.1% ﹤0.01% 3708
2015
Q4
$176K Buy
107,721
+7,612
+8% +$12.4K ﹤0.01% 3725
2015
Q3
$234K Buy
100,109
+258
+0.3% +$603 ﹤0.01% 3621
2015
Q2
$272K Sell
99,851
-14,748
-13% -$40.2K ﹤0.01% 3473
2015
Q1
$383K Buy
114,599
+4,392
+4% +$14.7K ﹤0.01% 3302
2014
Q4
$382K Buy
110,207
+162
+0.1% +$562 ﹤0.01% 3303
2014
Q3
$553K Buy
110,045
+108
+0.1% +$543 ﹤0.01% 3118
2014
Q2
$1.52M Buy
109,937
+35,865
+48% +$495K ﹤0.01% 2545
2014
Q1
$1.13M Buy
74,072
+1,203
+2% +$18.4K ﹤0.01% 2709
2013
Q4
$588K Buy
72,869
+28,484
+64% +$230K ﹤0.01% 3013
2013
Q3
$443K Buy
44,385
+11,257
+34% +$112K ﹤0.01% 3006
2013
Q2
$141K Buy
+33,128
New +$141K ﹤0.01% 3337